Effects of Sacubitril/Valsartan According to Natriuretic Peptide Levels in Patients Enrolled in PARADIGM-HF and PARAGON-HF.

RPEP-118972025Kondo, Toru; Jhund, Pardeep S; Anand, Inder S; Claggett, Brian L; Desai, Akshay S; Docherty, Kieran F; Lam, Carolyn S P; Lefkowitz, Martin P; Maggioni, Aldo P; Martinez, Felipe A; Redfield, Margaret M; Rouleau, Jean L; Van Veldhuisen, Dirk J; Zannad, Faiez; Zile, Michael R; Packer, Milton; Solomon, Scott D; McMurray, John J V

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Effects of Sacubitril/Valsartan According to Natriuretic Peptide Levels in Patients Enrolled in PARADIGM-HF and PARAGON-HF.

JACC. Heart failure, 13(6), 927-939

View on PubMed ↗Publisher’s paper ↗

Citation

Kondo, Toru; Jhund, Pardeep S; Anand, Inder S; Claggett, Brian L; Desai, Akshay S; Docherty, Kieran F; Lam, Carolyn S P; Lefkowitz, Martin P; Maggioni, Aldo P; Martinez, Felipe A; Redfield, Margaret M; Rouleau, Jean L; Van Veldhuisen, Dirk J; Zannad, Faiez; Zile, Michael R; Packer, Milton; Solomon, Scott D; McMurray, John J V. (2025). Effects of Sacubitril/Valsartan According to Natriuretic Peptide Levels in Patients Enrolled in PARADIGM-HF and PARAGON-HF.. JACC. Heart failure, 13(6), 927-939. https://doi.org/10.1016/j.jchf.2024.12.010